The University of Chicago Header Logo

Search Results (443)

MatchTypeWhy
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer.Academic Article Why?
[New chemotherapy regimens for advanced bladder cancer].Academic Article Why?
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.Academic Article Why?
Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC).Academic Article Why?
FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.Academic Article Why?
Identifying better practices for early-stage bladder cancer.Academic Article Why?
Novel cryotherapy in non-muscle-invasive bladder cancer.Academic Article Why?
Targeted therapies in bladder cancer--an update.Academic Article Why?
The current status of bladder preservation in the treatment of muscle invasive bladder cancer.Academic Article Why?
Three differentiation states risk-stratify bladder cancer into distinct subtypes.Academic Article Why?
Trimodality therapy in bladder cancer: who, what, and when?Academic Article Why?
[Acute arthritis secondary to intravesical bacillus Calmette-Guérin for bladder cancer].Academic Article Why?
Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.Academic Article Why?
Are we making significant progress in the diagnosis and management of bladder cancer?Academic Article Why?
Bladder cancer pharmacogenomics: recent insights and future perspectives.Academic Article Why?
Per Page    Page  of 30last Nextnext
Prev
Search Criteria
  • Bladder Cancer
Filter by Type
_
Click "Why?" to see why an item matched the search.